Cargando…
Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy
Background: A great number of therapeutic limitations, such as chemoresistance, high dosage, and long treatments, are still present in cancer therapy, and are often followed by side effects such as infections, which represent the primary cause of death among patients. Methods: We report pH- and enzy...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769784/ https://www.ncbi.nlm.nih.gov/pubmed/31510037 http://dx.doi.org/10.3390/cancers11091338 |